Castuner

IBD Essentials

Axel Dignaß

We are dedicated IBD clinicians and researchers trying to bring you the latest updates in science and teaching of GI endoscopy. Host Axel Dignaß and his co-hosts Ailsa Hart, Iris Dotan and Florian Rieder speak with renown guest from all over the world. We are grateful to our sponsors abbvie, Falk Foundation e.V. and Olympus.

Poddens webbplats

Lyssna i din app

Avsnitt

26 avsnitt

  1. Treatment Targets in IBD 2026 and beyond 23:42
  2. STRIDE-III: updated treatment targets in IBD 21:05
  3. Optimal treatment strategy in Crohn's disease 28:45
  4. Epidemiology and management of microscopic colitis 24:02
  5. Pregnancy in IBD (2) 23:50
  6. Inflammable bowel disease (IBD) in India 24:07
  7. Pregnancy in IBD 22:20
  8. Special Aspects of IBD management in Japan, monitoring strategies and medical treatment in IBD patients 22:59
  9. The Stenova trial: A new treatment option with Ontunisertib in fibrostenosing CD 25:22
  10. Special Aspects of IBD management in South America, Early Surgery in Crohn's disease and the emerging role of robotic surgery in IBD surgery 25:32
  11. Special Aspects of IBD management in the Middle-East and career pathways of women in GI and IBD 22:54
  12. Biography and credos of Jean-Fred Colombel and strategies for prevention and very early modification of IBD 24:24
  13. Biography of Bruce Sands and breaking the therapeutic ceiling in IBD 24:05
  14. Management of postoperative Crohn's disease 24:03
  15. Recent BSGE guidelines of chromoendoscopy 20:15
  16. Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies 23:56
  17. Relevance of cell-based therapies in IBD including hematopoetic stem cell transplantation and CAR T cell therapies 24:24
  18. Discussion about the role of B cells in health and other autoimmune diseases with highlighting the recent groundbreaking observations of B cell directed CART cell therapy in IBD 29:29
  19. Introduction of Ailsa Hart as Co-Host of IBD Essentials and Management of Perianal Crohn's disease 25:59
  20. Introduction of Florian Rieder as Co-Host of IBD Essentials and Fibrosis in IBD: A new target for evaluation and treatment 23:46
  21. How medical guidelines can improve the management of IBD 25:58
  22. Why should students and junior doctors pursue a career in IBD and how can UEG help? 22:51
  23. Emerging relevance of AI in the management of IBD 25:27
  24. Role of nutrition in the etiopathogenesis and treatment of IBD 25:57
  25. Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD 24:26
  26. Meet the Editor Axel Dignass of our new series IBD Essentials 27:28